波士顿科学股票在第三季度升12.5%,超过了预期收益,并获得"买入"评级. Boston Scientific's stock surged 12.5% in Q3, exceeding earnings estimates and securing a "Buy" rating.

波士顿科学公司 (BSX) 在第三季度的股价上了12.5%,最近报告每股收益 (EPS) 为0.70美元,超过预期的0.05美元. Boston Scientific Co. (BSX) saw its stock rise by 12.5% in Q3, and it recently reported earnings per share (EPS) of $0.70, beating estimates by $0.05. 该公司的市场上限为1 384.2亿美元, 分析师的“Buy”评级为“Buy”, 标价为108.91美元。 The company, whose market cap is $138.42 billion, has a "Buy" rating from analysts with a price target of $108.91. 机构投资者持有89.07%的股票,其中包括AGF管理有限公司和资本世界投资者。 Institutional investors hold 89.07% of the stock, including AGF Management Ltd. and Capital World Investors. 分析员预测波士顿科学公司本年度将设置2.85 EPS。 Analysts predict Boston Scientific will post 2.85 EPS for the year.